Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
boston
2
×
boston blog main
boston top stories
clinical trials
life sciences
national blog main
allergan
avapritinib
blueprint medicines
crispr
cstone pharmaceuticals
cynthia collins
deals
drugs
editas medicine
eli lilly
european medicines agency
fda
fisogatinib
flatiron health
gene editing
genentech
hepatocellular carcinoma
investing
jeff albers
katrine bosley
leber congenital amaurosis
medullary thyroid cancer
national top stories
non-small cell lung cancer
pralsetinib
roche
san francisco blog main
san francisco top stories
selpercatinib
thermo fisher scientific
thyroid cancer
What
regulatory
2
×
allergan
approval
blessing
blueprint
bosley
cancer
candidate
ceo
check
clinical
crispr
currently
cusp
depart
drug
editas
editing
experimental
fda
gene
humans
katrine
marketing
medicine
medicines
million
muscle
pact
partner
ret
review
roche
team
test
therapy
trial
wins
Language
unset
Current search:
regulatory
×
biotech
×
boston
×
@xconomy.com
4 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial